Lasting longer without oxygen: The influence of hypoxia on Notch signaling  by Pear, Warren S. & Simon, M. Celeste
	 p r e v i e w sLasting longer without oxygen: The influence of hypoxia on  
Notch signaling
Notch signaling has multiple functions during invertebrate and vertebrate development, where it plays important roles in cell 
fate determination, proliferation, survival, and border formation. The precise function of Notch signaling is context dependent, 
and one of the unsolved mysteries of Notch signaling is how a relatively stereotyped signal transduction pathway exerts 
such a wide variety of context-specific responses. Recent data from Gustaffson et al. provide important new information on 
this topic by showing that hypoxia enhances Notch signaling due to the association of Notch and HIF-1α. This interaction 
may have important consequences for tumor cell growth.Low levels of tissue oxygen, or hypox-
ia, can be caused by coronary artery 
disease, stroke, or the growth of solid 
tumors. Hypoxic microenvironments 
also occur during embryogenesis and in 
the adult, where one consequence may 
be the creation of niches that maintain 
pluripotential cells (Simon et al., 2002). 
Work in hematopoietic and neural stem 
cells showed that culturing progenitors in 
hypoxic conditions (3%–5% O2) increased 
the number of multipotent clones in com-
parison to normoxic cultures (21% O2) 
(Adelman et al., 1999; Morrison et al., 
2000). In addition, culturing progenitors 
under hypoxic conditions leads to differ-
ent developmental outcomes than culture 
in normoxic conditions. For example, 
culturing CNS precursors under hypoxic 
conditions skews differentiation toward 
the dopaminergic fate. Besides effects 
on differentiation and cell fate, hypoxia 
promotes survival and increases the pro-
liferation of multipotent precursors.
Some of the effects of hypoxia on 
stem cells correlate with the effects of 
Notch signaling on these cells. Notch is 
able to both maintain the pluripotential 
state of some cells and induce specific 
cell fates. Notch also influences prolif-
eration and survival. In the November 
issue of Developmental Cell, the studies 
of Gustaffson et al. provide important 
evidence showing that hypoxia directly 
influences Notch signaling (Gustafsson 
et al., 2005). In this work, hypoxia caused 
HIF-1α to potentiate Notch activation. In 
both myogenic and neural precursor cell 
lines, hypoxia inhibited differentiation, 
an effect that was abrogated in the pres-
ence of γ-secretase inhibitors, which can 
inhibit Notch signaling. In P19 embryonic 
carcinoma cells, which undergo neuronal 
differentiation in response to Notch sig-
naling, hypoxia caused a 4-fold increase 
in the Notch transcriptional target Hes1. 
The hypoxic effects were mimicked by 
known promoters of HIF-1α stability, 
suggesting that HIF-1α directly medi-cancer cell : december 2005 · Vol. 8 · coates the effects of hypoxia on Notch. The 
association between HIF-1α and Notch 
was confirmed by immunoprecipitation of 
in vitro translated proteins, which identi-
fied both proteins in the same complex. 
Although the Notch:HIF-1α association 
did not require the HIF-1α C terminus, 
which is required for p300 recruitment, 
enhanced transcriptional activation via 
Notch did require the HIF-1α C terminus 
and presumably p300 recruitment.
It is of particular interest that hypoxia 
appeared to enhance the stability of intra-
cellular Notch (ICN). In P19 cells, hypoxia 
caused a HIF-1α-dependent increase in 
ICN levels, suggesting that HIF-1α stabi-
lizes ICN. Similar results were obtained 
in HIF-1α-transfected COS7 cells. 
Normally, nuclear ICN is a very short-
lived protein. Mammalian Notch signal-
ing is initiated when ligands of either the 
Delta or Jagged family bind one of four 
Notch receptors (Figure 1A). This results 
in a series of proteolytic cleavages, the 
first mediated by an ADAM metallopro-
tease and the second by γ-secretase. 
The final cleavage releases ICN (Selkoe 
and Kopan, 2003), which contains a set 
of functionally crucial ankyrin repeats, 
a C-terminal PEST domain, and two 
nuclear localization sequences that 
guide ICN into the nucleus. Once there, 
ICN recruits a member of the Mastermind 
family (MAML) and other transcriptional 
activators, such as p300. Recent work 
has shown that transcriptional activation 
by Notch requires the ternary transcrip-
tional activation complex of CSL, ICN, 
and MAML (Fryer et al., 2002; Wallberg 
et al., 2002). Normally, nuclear ICN is 
extremely short lived; in early studies, its 
existence was largely inferred indirectly 
from reporter gene and functional assays 
(Mumm and Kopan, 2000). Recent work 
suggests that MAML functions not only in 
transcriptional activation (which involves 
recruitment of p300), but also in ICN turn-
over (Fryer et al., 2002, 2004; Wallberg 
et al., 2002). The latter activity is corre-pyright © 2005 elseVier inc. lated with phosphorylation of the Notch 
C-terminal PEST domain by CycC:CDK8 
(Fryer et al., 2004), an event that may 
promote PEST-dependent degradation 
by the Fbw/Sel10 ubiquitin ligase.
Although the data from Gustaffson 
et al. showed that ICN and HIF-1α can 
be coimmunoprecipitated, their precise 
relationship is unclear (Figure 1B). One 
possibility is that HIF-1α is recruited to 
the CSL:ICN:MAML ternary complex. 
In this scenario, HIF-1α could interfere 
with the ability of MAML to promote the 
degradation of ICN, and thereby pro-
long Notch signaling. Another possibil-
ity is that HIF-1α replaces MAML in the 
ternary complex. Data from the Jones 
and Roeder groups showed that MAML 
recruits p300 to the complex (Fryer et 
al., 2002; Wallberg et al., 2002); thus, 
HIF-1α, whose activity requires p300, 
would bind Notch and bring p300 into the 
complex. Again, in this scheme HIF-1α 
is less efficient than MAML in promoting 
ICN degradation. Another possibility is 
that ICN and HIF-1α associate indirectly 
in the same complex through contacts 
with other proteins. Although p300 is an 
attractive candidate, the structure/func-
tion studies of Gustaffson et al. appear to 
rule this out, as HIF-1α mutants that are 
unable to bind p300 coimmunoprecipitat-
ed with ICN. Other questions raised by 
the Gustafsson et al. findings are wheth-
er HIF-1β associates with the complex 
and how to interpret the association of 
the HIF-1α inhibitor FIH with ICN.
The ICN:HIF-1α complex appears to 
stimulate CSL-dependent Notch signal-
ing. This raises the question of whether 
hypoxia regulates transcription of all 
CSL:Notch transcriptional targets or 
only a subset. In the current work, only 
two promoters were examined, Hey-2 
and Hes-1, both of which are activated 
by Notch in a wide variety of cell types 
and contexts. Whether hypoxia selects 
for a specific subset of Notch targets 
remains to be determined. It is also not 435
	 p r e v i e w sFigure 1. models depicting potential interactions of hiF-1α with icn
a: the canonical hiF-1α and notch:csl signaling pathways are shown. hypoxia ultimately leads 
to creation of the hiF-1α:hiF-1β transcriptional activation complex that initiates transcription 
of specific genes, some of which are shown. the details of the notch signaling pathway are 
discussed in the text.
B: potential interactions of hiF-1α with icn in the nucleus. the left panel shows a direct interaction 
of hiF-1α with icn. in this model, hiF-1α substitutes for mAml. it is not known if the hiF-1α interaction 
first occurs outside or within the nucleus. in the middle panel, hiF-1α interacts with icn through 
a bridging protein. one possibility is mAml. As discussed in the text, p300 is unlikely. in the right 
panel, both mAml and hiF-1α are recruited to the csl:icn transcriptional activation complex. 
note that both hiF-1α and mAml can bind p300.known whether HIF-1α interacts with all 
four mammalian Notch receptors. The 
experiments of Gustafsson et al. relied 
on overexpression of ICN1 or chromatin 
immunoprecipitation with Notch1-specific 
reagents, leaving open the question of 
whether similar effects are exerted by the 
other Notch receptors.
In addition to HIF-1α, other proteins 
have also been shown to modulate ICN 
turnover in both normal and pathological 436 situations. Artavanis-Tsakonis and col-
leagues recently identified a trimolecular 
complex between Notch, Deltex, and the 
nonvisual β-arrestin Krz, which enhanced 
degradation of ICN (Mukherjee et al., 
2005). Recent work from the Aster and 
Look labs showed that the majority of 
human T cell lymphoblastic leukemias (T-
ALL) have Notch1 mutations (Weng et al., 
2004). At least one-third of these tumors 
have mutations that create frameshifts or introduce premature stop codons that 
result in deletion of the C-terminal PEST 
sequences and prolonged ICN1 half-life. 
These data indicate that dysregulated 
control of nuclear Notch turnover plays 
a role in certain human cancers.
In contrast to T-ALL, C-terminal 
Notch mutations have not been identi-
fied in other human tumors. Yet many 
tumors, such as breast cancer and pan-
creatic cancer, show elevated levels of 
Notch expression and signaling (Radtke 
and Raj, 2003). An interesting possibility 
is that hypoxia, rather than Notch muta-
tions, leads to enhanced Notch signaling 
in these cells through HIF-1α expression. 
Whether this is functionally important can 
be addressed by treating tumor cells with 
inhibitors of the canonical Notch signal-
ing pathway. Such experiments will not 
only reveal whether the elevated levels 
of Notch signaling influence the growth, 
survival, and/or differentiation of tumor 
cells, but may provide a rationale for new 
therapeutic interventions directed at the 
Notch pathway.
Although the Gustaffson et al. paper 
focuses on cell-autonomous effects of 
Notch signaling, hypoxia alters the tumor 
microenvironment as well. Accumulating 
evidence shows that Notch plays an 
important role in establishing arterial fate 
(Alva and Iruela-Arispe, 2004). Recent 
work also demonstrated a potential role 
for Notch in tumor angiogenesis. Zeng 
et al. reported that MAPK-dependent 
upregulation of the Notch ligand Jagged1 
in some tumor cells promoted Notch-
dependent tumor vascularization (Zeng 
et al., 2005). Whether HIF-1α influences 
this function of Notch is not known. An 
interesting possibility from the Notch:
HIF-1α association is that small molecule 
inhibitors of HIF-1α (Kong et al., 2005) 
may serve as context-dependent inhibi-
tors of Notch signaling
In summary, the exciting work of 
Gustafsson et al. provides a new van-
tage from which to consider the influ-
ence of Notch signaling. Although much 
of the details remain to be determined, 
there appears to be a close link between 
hypoxic signaling and Notch. As both 
of these pathways are associated with 
multiple aspects of neoplasia, it will be 
important to determine the precise con-
texts in which these pathways influence 
the transformed state. Hopefully, these 
results will guide the development of 
therapeutics based on the intersection 
of Notch and hypoxic signaling.cancer cell : december 2005
	 p r e v i e w sWarren s. pear1,2,* and  
m. celeste simon1,3
1Abramson Family cancer research 
institute, University of pennsylvania, 
421 curie boulevard, philadelphia, 
pennsylvania 19104 
2department of pathology and 
laboratory medicine/institute for 
medicine and engineering, University 
of pennsylvania, 421 curie boulevard, 
philadelphia, pennsylvania 19104 
3department of cell and developmental 
biology/howard hughes medical institute, 
University of pennsylvania, 421 curie 
boulevard, philadelphia, pennsylvania 
19104 
*e-mail: wpear@mail.med.upenn.edu
Selected reading
Adelman, D.M., Maltepe, E., and Simon, M.C. 
(1999). Genes Dev. 13, 2478–2483.cancer cell : december 2005 
Akt modulates a variety of cellular proc-
esses, including proliferation, growth, and 
survival, by phosphorylating target pro-
teins involved in these processes (recently 
reviewed in Bellacosa et al., 2004; Brazil 
et al., 2004; Osaki et al., 2004; Woodgett, 
2005). Many signaling pathways activate 
Akt through phosphatidylinositol-3-kinase 
(PI3K). PI3K converts phosphatidylinosi-
tol-4,5-bis-phosphate (PIP2) to phos-
phatidylinositol-3,4,5-triphosphate (PIP3). 
PIP3 recruits Akt to the membrane where 
Akt is activated. PTEN dephosphorylates 
PIP3 and antagonizes PI3K function. 
Additionally, several molecules, such as 
CTMP, TRB3, and PHLPP, bind to and 
directly regulate Akt (Brazil et al., 2004; 
Gao et al., 2005).
Well-characterized substrates of Akt 
include antiapoptotic proteins, such as 
FOXO, BAD, and IKK-β; cell cycle regula-
tors, such as p27kip1, p21cip1, MDM2, and 
Myt1; and GSK-3, which is involved in a 
A knotty turnabout?: A
Akt is well known to enhance malignancy
findings reported by Yoeli-Lerner et al. in th
tion of Akt: activation of Akt1 inhibited inv
was that Akt activated the E3 ubiquitin lig
factor. These findings clearly justify furthe
therapeutic strategies currently under deAlva, J.A., and Iruela-Arispe, M.L. (2004). Curr. 
Opin. Hematol. 11, 278–283.
Fryer, C.J., Lamar, E., Turbachova, I., Kintner, C., 
and Jones, K.A. (2002). Genes Dev. 16, 1397–
1411.
Fryer, C.J., White, J.B., and Jones, K.A. (2004). 
Mol. Cell 16, 509–520.
Gustafsson, M.V., Zheng, X., Pereira, T., Gradin, 
K., Jin, S., Lundkvist, J., Ruas, J.L., Poellinger, L., 
Lendahl, U., and Bondesson, M. (2005). Dev. Cell 
9, 617–628.
Kong, D., Park, E.J., Stephen, A.G., Calvani, 
M., Cardellina, J.H., Monks, A., Fisher, R.J., 
Shoemaker, R.H., and Melillo, G. (2005). Cancer 
Res. 65, 9047–9055.
Morrison, S.J., Csete, M., Groves, A.K., Melega, 
W., Wold, B., and Anderson, D.J. (2000). J. 
Neurosci. 20, 7370–7376.
Mukherjee, A., Veraksa, A., Bauer, A., Rosse, 
C., Camonis, J., and Artavanis-Tsakonas, S. 
(2005). Nat. Cell Biol., in press. Published online variety of processes (Brazil et al., 2004). 
Akt has also been shown to stimulate 
angiogenesis via regulation of eNOS 
and increase cell metabolism through 
the mTOR/p70S6K pathway (Luo et al., 
2003). Additionally, Akt stimulates MMP 
secretion, activates the small GTPase 
Rac, and promotes epithelial-to- mesen-
chymal transition (EMT), three attributes 
that can lead to increased metastatic 
potential (Bellacosa et al., 2004; Luo et 
al., 2003; Zhou et al., 2004). In light of 
Akt’s involvement in all these pathways, 
it is not surprising that Akt protein levels, 
enzymatic activities, and even gene copy 
numbers are increased in many different 
types of tumors. Akt upregulation has 
been seen in carcinomas of the prostate, 
breast, ovary, pancreas, colon, stomach, 
and thyroid (Luo et al., 2003; Osaki et 
al., 2004). The importance of increased 
Akt activity in tumorigenesis is further 
underscored by the identification of gain-
kt1 as a metastasis sup
 and is recognized as a key target for antine
e November 23, 2005 issue of Molecular Ce
asion in some cancer cells. One possible m
ase HDM2, causing ubiquitination and degr
r investigations and, if validated in vivo, ca
velopment.November 13, 2005. 10.1038/ncb1327.
Mumm, J.S., and Kopan, R. (2000). Dev. Biol. 228, 
151–165.
Radtke, F., and Raj, K. (2003). Nat. Rev. Cancer 
3, 756–767.
Selkoe, D., and Kopan, R. (2003). Annu. Rev. 
Neurosci. 26, 565–597.
Simon, M.C., Ramirez-Bergeron, D., Mack, F., 
Hu, C.J., Pan, Y., and Mansfield, K. (2002). Cold 
Spring Harb. Symp. Quant. Biol. 67, 127–132.
Wallberg, A.E., Pedersen, K., Lendahl, U., and 
Roeder, R.G. (2002). Mol. Cell. Biol. 22, 7812–
7819.
Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P., 
IV, Silverman, L.B., Sanchez-Irizarry, C., Blacklow, 
S.C., Look, A.T., and Aster, J.C. (2004). Science 
306, 269–271. 
Zeng, Q., Li, S., Chepeha, D.B., Giordano, T.J., Li, 
J., Zhang, H., Polverini, P.J., Nor, J., Kitajewski, J., 
and Wang, C.Y. (2005). Cancer Cell 8, 13–23.
DOI: 10.1016/j.ccr.2005.11.016437
of-function mutations in PI3K and loss of 
expression of the PTEN tumor suppressor 
gene in many tumors, which positively and 
negatively regulate Akt activation, respec-
tively (Luo et al., 2003; Osaki et al., 2004; 
Saal et al., 2005).
Given these well-established mecha-
nisms by which Akt activation promotes 
transformation, a publication by the Toker 
laboratory in the November 23, 2005 issue 
of Molecular Cell suggests a surprising 
twist on Akt’s role in the tumorigenic proc-
ess (Yoeli-Lerner et al., 2005). Compelling 
in vitro evidence indicates that Akt blocked 
motility and invasion, important metasta-
sis-related properties, in three different 
breast cancer cell lines. This was studied 
by artificially activating Akt1 and also by 
activating Akt with IGF-1 as a physiologi-
cal stimulus. Conversely, lowering Akt1 
levels with siRNA restored, and in some 
cases enhanced, the invasive properties 
of the cells. The kinase activity of Akt was 
pressor
oplastic therapies. However, intriguing 
ll, suggest a novel, antimetastasis func-
echanism for this surprising phenotype 
adation of NFAT, an invasion-promoting 
ll for reevaluation of some Akt-targeting 
